Ealixir, Inc.
EAXR · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -7.83 | 0.17 | -14.67 | 20.71 |
| FCF Yield | 0.47% | 0.28% | -0.06% | -0.16% |
| EV / EBITDA | 353.52 | -88.30 | 1,094.21 | -1,407.45 |
| Quality | ||||
| ROIC | -146.36% | 385.56% | 159.93% | 115.43% |
| Gross Margin | 86.34% | 74.12% | 78.81% | 75.57% |
| Cash Conversion Ratio | 4.19 | -0.34 | -0.70 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.34% | 12.60% | 35.31% | 38.92% |
| Free Cash Flow Growth | 17.19% | 287.95% | 67.25% | 54.31% |
| Safety | ||||
| Net Debt / EBITDA | 0.21 | -0.22 | 2.52 | -1.90 |
| Interest Coverage | -15.97 | -27.71 | 10.08 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 13.98 | 0.00 | 0.00 |
| Cash Conversion Cycle | -208.62 | -36.50 | -36.08 | -71.38 |